Swan Capital LLC Exact Sciences Corp Transaction History
Swan Capital LLC
- $205 Billion
- Q4 2024
A detailed history of Swan Capital LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Swan Capital LLC holds 2,000 shares of EXAS stock, worth $112,340. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$112,340
Previous $136 Million
17.51%
% of portfolio
0.05%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
641Shares Held
155MCall Options Held
1.74MPut Options Held
1.54M-
Capital World Investors Los Angeles, CA17.8MShares$1 Billion0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$991 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$702 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$678 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$372 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.94B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...